Abstract 137: Improved glycemic control among people with type 2 diabetes with a digital therapeutics approach in collaboration with clinicians

Background: Due to poor diabetes self-management awareness as well as heavy patient burden, management of diabetes in India is challenging for clinicians. Digital therapeutics platforms provide accessible and cost-efficient care through evidence-based guidance for lifestyle and behavioural modifications. Aim and Objectives: To evaluate the effectiveness of Diabefly ® digital therapeutics platform for glycemic control among people with type 2 diabetes. Results: De-identified data of 144 participants referred by physicians (mean age: 46.42 years, 54.54 % females) on the 90 days Diabefly ® program was analyzed. A mean significant reduction in HbA1C was observed by 1.56% ( P < 0.001) from baseline 8.59%. Similarly, mean weight and BMI significantly reduced by 2.39 kg and 0.84 kg/m 2 ( P